Partner, Patent Attorney / London
Patents - biotechnology, chemistry & pharmaceuticals group
Patent litigation, arbitration & mediation group
Zöe’s area of expertise is chemistry, including small molecule pharmaceutical and veterinary chemistry. Zöe also handles subject matter relating to therapeutic/diagnostic methods, process chemistry, antisense RNA technology, polymers, polymorphs and formulation chemistry. Zöe’s clients include academic/research institutes, start-up companies, biotech/pharmaceutical SMEs and larger blue chip companies.
Zöe joined D Young & Co in 1998 and became a partner in 2004. Zöe’s practice involves drafting, prosecution, oppositions and appeals and freedom to operate opinion work. Zöe also regularly advises small clients on IP due diligence for project acquisitions, investment/licensing opportunities and stock market flotations.
"Exemplary" IP Stars 2016 (Managing IP)
"Clients describe Zöe Clyde-Watson as being 'in a class of her own'" Who's Who Legal.
Zöe "receives praise for 'bringing real value to a matter'" Who's Who Legal.
MA in Natural Sciences, St. Catharine’s College, University of Cambridge.
PhD in organic chemistry, University of Cambridge (Research into porphyrin-based receptors, their synthesis and intracavity chemistry).
Postdoctoral research, University of Cambridge (Investigating a combinatorial approach to synthesising macrocyclic receptors in the presence of transition state analogues).
Certificate in Intellectual Property Law, Queen Mary College, University of London.
European Patent Attorney 2002.
Chartered Patent Attorney 2002.
European Design Attorney.
Chartered Institute of Patent Attorneys (CIPA).
European Patent Institute (epi).
Ethyne-linked cyclic porphyrin oligomers: Synthesis and binding properties, J. Org. Chem., 1997, 62, 240.